|
Symposia
Milestone Development Services organizes the annual
symposium on Chemical and Pharmaceutical Structure
Analysis (CPSA). This unique event features the
discussion of industry related applications.
Comprehensive perspectives on industry-related
issues and needs, analysis strategies, and
performance benchmarks are discussed within program
formats promoting interaction and discussion. The
purpose is to provide an "incubator" for accelerated
development.
Milestone is available to assist with organizing a symposium for your specific needs.

Beyond Optimization: Enabling Biology Through Analytical Innovation
Plenary Lecture:
R. Graham Cooks, Purdue University
Program Chair:
Bradley L. Ackermann, Eli Lilly and Company
The event will be held in Princeton, New Jersey - October 17 - 20, 2005
CPSA 2005 »
Integrated Approaches to Drug Discovery & Development:
Turning Measurements to Medicine
Plenary Lecture:
Quantitative and Ultra-sensitive High Throughput Proteomics
Richard D. Smith, Pacific Northwest National Laboratory
Program Chairs:
Steven A. Hofstadler, Ibis Therapeutics
Mark Sanders, Bristol-Myers Squibb
The event was held in Princeton, New Jersey - October 19 - 21, 2004
View CPSA 2004 Digest »
From Proteomics to the Pill: New Initiatives in Proteomics, Drug Discovery, and Development
Plenary Lecture:
The Multi-Dimensionality of the Proteome
Simon J. Gaskell, The University of Manchester Institute of Science and Technology
The event was held in Princeton, New Jersey on September 22-24, 2003
Kenny Morand, (Proctor & Gamble) was the Organizing Chair
View CPSA 2003 Digest »
Emerging Standards for Drug Discovery and Development: Perspectives on Technology, Strategy and Relationships
Plenary Lecture:
The Economics of Pharmaceutical Innovation: Trends in Costs, Risks and Returns
Joseph A. DiMasi, Ph.D. Director of Economic Analysis, Tufts Center for the Study of Drug Development
The event was held in Princeton, New Jersey on October 8-10, 2002
Kenny Morand, (Proctor & Gamble) was the Organizing Chair
View CPSA 2002 Digest »
New Technologies and Approaches for Increasing Drug Candidate Survivability: Lead Identification to Lead Optimization
Plenary Lecture:
Of Mice and Magnets: Metabonomic Technology as a Tool for Rapid-Throughput Toxicity Evaluation
Donald G. Robertson Pfizer Global R&D.
The event was held in Princeton, New Jersey on October 8-11, 2001
Robyn Rourick (DuPont Pharmaceuticals) was the Organizing Chair
View CPSA 2001 Digest »
Techniques and Trends for High Throughput Analysis
Dr. Lee, working with Dr. Gillespie and each chair/discussion leader, delineates ideas expressed during roundtable sections.
The CPSA in 2000 was expanded to include roundtable discussions focusing on the theme Techniques and Trends for High
Throughput Analysis and featured sessions that highlighted industry-related applications. The format was aimed at
stimulating unique discussion on needs, issues, and benchmarks for analytical performance. The focus was on development
solutions for industry scientists and managers (i.e., commercial technologies, mainstream applications, analysis trends).
The event was held in Princeton, New Jersey on September 26-28, 2000.
View CPSA 2000 Digest »
|